7 November 2012 |
| 16:00-16:45 | | RegistrationLeeds Town Hall |
| 16:45-17:30 | | RegistrationLeeds City Museum, Leeds |
| 17:30-19:00 | | Ferring Pharmaceuticals Satellite SymposiumChair(s):Tim Cheetham (Newcastle upon Tyne)Regulation of Salt and WaterLeeds City Museum, Leeds |
| | Diabetes Insipidus and Pituitary Stalk AbnormalitiesMohamad Maghnie (Genova, Italy) |
| | Other forms of salt and water disturbanceSteve Ball (Manchester, United Kingdom) |
| 19:00-19:45 | | Welcome ReceptionLeeds City Museum, Leeds |
8 November 2012 |
| 08:15-17:00 | | Registration Opens |
| 08:45-09:00 | | WelcomeChair(s):S Alvi (Leeds) & T Mushtaq (Leeds) |
| 09:00-10:30 | | Oral Communications 1 |
| OC1.1 | Iodine status in UK pregnant women and implications for fetal brain development |
| OC1.2 | Disease- and treatment-related factors implicated in late neuroendocrine morbidity after paediatric optic pathway gliomas: a preliminary multivariate analysis of 96 patients treated over 30 years. |
| OC1.3 | Potential novel insights into the control of the feto-placental unit by kisspeptin. |
| OC1.4 | Skeletal effects of hypothyroidism are mediated by thyroid hormone receptor alpha. |
| OC1.5 | Ethnic Differences In Vascular Growth Factor Levels In Early Life In Relation To Arterial Stiffness In The Manchester Heart And Growth Study |
| OC1.6 | A novel syndrome characterized by hypothalamic hormonal insufficiency, neonatal seizures, congenital abnormalities of the kidneys and urinary tract and obesity due to mutation in a gene regulating hypothalamic development |
| OC1.7 | Novel therapies herald novel diseases: The first paediatric case series of Graves’ immune reconstitution disease |
| OC1.8 | Loss-of-Function Mutations in IGSF1 Cause a Novel, X-Linked Syndrome of Central Hypothyroidism and Testicular Enlargement |
| 10:30-11:00 | | Tea & Coffee |
| 11:00-12:00 | | Symposium 1Chair(s):S Alvi (Leeds) & G Butler (London)Gender Identity Development - Care and Controversies |
| 11:00 | S7 | The development of sexual identity and understanding of GIDP Carmichael (London) |
| 11:30 | S8 | Gender reassignment surgery in GIDJ Bellringer (London) |
| 12:00-13:30 | | Lunch |
| 12:45-13:30 | | Poster Tour |
| 13:30-14:30 | | Symposium 2Chair(s):M Dattani (London) & H Storr (London)Controversies in Paediatric Endocrinology |
| 13:30 | S9 | Growth Hormone in transitionM Maghnie (Genova, Italy) |
| 14:00 | S10 | MEN Syndromes- the genetics and ethics of screeningC Chu (Leeds) |
| 14:30-15:30 | | Oral Communications 2 |
| OC2.1 | Assessment of adrenal function in Female to Male adolescents with Gender Identity Dysphoria (GID). |
| OC2.2 | Deficiency of the triple A syndrome gene product, ALADIN, renders human adrenal cells susceptible to oxidative stress with subsequent impact on steroidogenesis |
| OC2.3 | Does Vitamin D modulate mitochondrial oxidative phosphorylation? |
| OC2.4 | Prenatal Dexamethasone For Treatment Of Congenital Adrenal Hyperplasia: A Possible Association With Late Gestational Fetal Demise In Two Cases. |
| OC2.5 | Abnormal neurological and developmental outcomes in children with persistent and spontaneously resolving congenital hyperinsulinism |
| OC2.6 | Childhood body composition is associated with maternal plasma polyunsaturated fatty acids status in late pregnancy |
| OC2.7 | Growth, GH-IGF-I Status and Response to r-hGH Therapy in 3-M Syndrome, Related to Mutation Status |
| OC2.8 | Genetic screening in a large cohort of patients with congenital hypopituitarism; current knowledge and future directions. |
| OC2.9 | Growth hormone (GH) neuro-secretory dysfunction following traumatic brain injury (TBI) in childhood |
| OC2.10 | When is it justifiable to await venous thyroid function tests before starting thyroxine treatment in infants referred with capillary TSH elevation? |
| 15:30-16:00 | | Tea & Coffee |
| 16:00-17:00 | | Symposium 3Chair(s):T Mushtaq (Leeds) & J Wales (Sheffield)The Olympiad! |
| 16:00 | S11 | Beyond reasonable doubt – catching the GH cheatsR Holt (Southampton) |
| 16:30 | S12 | Physical Activity and Athletic Training in Children and AdolescentsA Rogol (Virginia, USA) |
| 17:15-18:00 | | BSPED Annual General Meeting |
| 19:15-20:00 | | Pre-Dinner Welcome Reception |
| 20:00-23:45 | | Conference Dinner |
9 November 2012 |
| 08:15-17:00 | | Registrations Opens |
| 09:00-10:00 | | Symposium 4Chair(s):F Campbell (Leeds) & T Barrett (Birmingham)Hot topics In Diabetes |
| 09:00 | S13 | Improving outcomes in teenagers and young adults with Type 1 diabetesS Heller (Sheffield) |
| 09:30 | S14 | Continuous age appropriate structured education for children and young people with diabetesK Lange (Hannover, Germany) |
| 10:00-10:30 | | Oral Communications 3 |
| OC3.1 | HbA1c league tables: Does selection policy encourage foul play to support promotion to the “premier league”? |
| OC3.2 | Audit of management of diabetic ketoacidosis in children |
| OC3.3 | Quality of Life and HbA1c outcomes in children and young people commencing insulin pump therapy |
| OC3.4 | Continuous Glucose Monitoring - Are there more barriers than benefits? |
| OC3.5 | Childhood Type I Diabetes Education at Time of Diagnosis- what Patients Want to Know |
| 10:30-11:00 | | Tea & Coffee |
| 11:00-12:00 | | Oral Communications 4 |
| OC4.1 | Metformin in Obese Children and Adolescents: the MOCA trial |
| OC4.2 | Patterns of presentation and initial management of type I diabetes mellitus in the UK: the Early Care Survey |
| OC4.3 | White UK children are older, more obese and more insulin resistant than non-White UK children at diagnosis of type 2 diabetes: baseline results of the UK national Type 2 diabetes cohort |
| OC4.4 | Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its stability and expression. |
| OC4.5 | The effect of insulin intensification on glycaemic control and lipid levels in children and young persons with type 1 diabetes differs in relation to ethnic group |
| 12:00-12:45 | | Symposium 5Chair(s):C Gelder (Leeds) & G Parfitt (Gwent, Wales) |
| S15 | Structured Knowledge and Information Programme-the SKIP courseN Lovell (Bristol) |
| S16 | How paediatric diabetes nurse specialists support schoolsM Marshall (Manchester) |
| 12:45-13:00 | | BSPED Prizes |
| 13:00-14:00 | | Lunch |
| 14:00-15:00 | | Symposium 6Chair(s):F Annan (Liverpool) & J Edge (Oxford)Diabetes and Sport |
| 14:00 | S17 | Physiology of exercise and endurance sport in type 1 diabetesR Andrews (Taunton) |
| 14:30 | S18 | Optimising sports performance and nutrition in type 1 diabetesG Regan (Newport) |
| 15:00-15:45 | | Keynote Lecture |
| 15:00 | S19 | Insulin pumps and continuous monitoring: evidence for their role in the management of diabetesJ Pickup ((London)) |
| 15:45-15:50 | | Closing remarks |